Statement by Blue Earth Diagnostics on COVID-19 click here for more information

Patient Resources

Our focus is on delivering innovative molecular imaging diagnostics and radiotherapeutics for cancer patients in areas of high unmet medical need. Our strategy is driven by science with a commitment to improve outcomes for patients

Patient Information Leaflet 

You can access approved Patient Information Leaflets for your selected country by using the drop down box below. Not all materials are relevant or available in each country.

If you are a patient in the United States of America (USA), please click here

Axumin is subject to additional monitoring. This will allow quick identification of new safety information.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

If you wish to report possible side effects associated with the use of the medicines of Blue Earth Diagnostics in Europe or the UK, please send an email to drugsafety@blueearthdx.com.  In the UK, you can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/.  By reporting side effects, you can help provide more information on the safety of this medicine.

If you wish to report possible side effects associated with the use of the medicines of Blue Earth Diagnostics in the USA or elsewhere in the world, please send an email to drugsafetyus@blueearthdx.com

Downloadable Information

Patient Information Leaflet

a